Jane Street’s Exagen XGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.5M Buy
322,502
+85,767
+36% +$323K ﹤0.01% 5700
2026
Q1
$710K Buy
236,735
+42,699
+22% +$165K ﹤0.01% 7252
2025
Q4
$1.18M Buy
194,036
+91,729
+90% +$835K ﹤0.01% 5797
2025
Q3
$1.12M Buy
+102,307
New +$906K ﹤0.01% 6072

Other funds holding XGN

Jane Street's XGN Position: Q2 2026 in Review

Jane Street increased its Exagen (XGN) stake by 36% in Q2 2026, buying an estimated $323K and bringing the position to 322,502 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #5700.

Jane Street first reported a position in XGN in Q3 2025 and has held it in 4 quarters since. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

  • Jane Street held 322,502 shares of Exagen worth $1.5M as of Q2 2026.
  • Jane Street bought 85,767 Exagen shares in Q2 2026, an estimated $323K.
  • Exagen made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #5700 holding.
  • Jane Street first reported a position in Exagen in Q3 2025 and has held it in 4 quarters since.
  • 57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.